Eurozone retail sales rose 1.0% mom in November, much better than expectation of -0.5%. Volume of retail trade increased by 1.6% for non-food products and by 0.6% for food, drinks and tobacco, while it fell Read more…
Eurozone inflation accelerated from 4.9% to 5.0% in December, above expectation of 4.7% yoy. That’s another record print since record began in 1991. CPI core was unchanged at 2.6% yoy, above expectation of 2.3% yoy. Read more…
UK PMI Construction dropped from 55.5 to 54.3 in December, above expectation of 53.9. Markit said weakness centered on commercial and civil engineering segments. House building regained its place as fastest-growing category. Suppliers delay were Read more…
All eyes are on US nonfarm payrolls, perhaps the monthly highlight on the economic calendar. An interesting prelude to nonfarm payrolls was the ADP employment report on Wednesday. ADP is not a reliable indicator for Read more…
GBPJPY’s strong two-week rally, which began from 149.50 has lost steam just shy of the 157.84 level and the more than 5-year high of 158.20, the former being the 161.8% Fibonacci extension of the down Read more…
The US 30 stock index (cash) has been experiencing a minor pullback in the last few four-hour sessions since its long-term rally peaked at the all-time high of 36,950. Moreover, the price crossed below its 50-period Read more…
USDCAD is facing difficulties in extending Monday’s swift bullish correction, which helped the pair survive a trend deterioration below the previous low of 1.2606 in the short-term window. Despite the flash pickup to 1.2812 yesterday, Read more…
USDCHF powered back from its late December low, halting a five session losing streak and crossing above the 50- and 200-day simple moving average (SMA). The cautiously bullish outlook for the pair is maintained despite Read more…
US employment report today could be critical for markets FX and stock markets quiet, but yield spike hurts gold Oil powers higher as supply disruptions get priced in Conflicting signs for US jobs The main Read more…
VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced that Read more…